Amyotrophic Lateral Sclerosis
FY26 Programmatic Panel:
Lyle Ostrow, M.D., Ph.D. (Chair)
Lewis Katz School of Medicine, Temple University
Martina de Majo, Ph.D.
International Alliance of ALS/MND Associations
Dan Elbaum, Ph.D.
QurAlis
Ernest Fraenkel, Ph.D.
Department of Biological Engineering, MIT
Maj. Timothy Fullam, M.D., U.S. Air Force Retired
Barrow Neurological Institute
Molly Hammell, Ph.D.
NYU Langone Health
Moon Han, Ph.D., M.P.H., M.Sc.
Centers for Disease Control and Prevention
Matt Harms, M.D.
Columbia University
Justin Kwan, M.D.
Division of Intramural Research, National Institute of Neurological Disorders and Stroke
Joseph Lewcock, Ph.D.
Denali Therapeutics, Inc.
Michael Robinson, M.D.
Patient Advisor, Healey Platform Trial
Ghazaleh Sadri-Vakili, Ph.D., M.S.
Harvard Medical School
Nadia Sethi, D.D.S.
Patient Education and Advocacy Committee, Northeast ALS Consortium
David Taylor, Ph.D.
ALS Society of Canada
Last updated Wednesday, March 11, 2026